A series of letters was sent Monday to Costco, Walmart, Kroger, Albertsons, and McKesson. Signers include Christian financial technology firm Inspire Insight, financial advisor David Bahnsen, and Guidestone Financial Services, as well as proxy voting and corporate engagement consultant Jerry Bowyer.
6,000 Costco members have also signed a petition to the membership-only big-box retailer.
Bowyer advises them to think twice about selling mifepristone.
"There are huge legal risks, and there are political risks," he tells AFN. "And I would add there're also financial risks involved with selling this product."
Jeremy Tedesco, Alliance Defending Freedom's (ADF) senior counsel and senior vice president of corporate engagement, points out that the legal landscape on chemical abortion drugs is anything but settled.
"The FDA's own label admits that roughly one in 25 women who take this drug will end up in the ER," he relays. "Retail pharmacies are there to serve the health and wellness of their customers, but abortion drugs like mifepristone undermine that mission by putting women's health at risk."
Apart from the moral aspect, Bowyer says selling the drug makes no sense from a financial standpoint, as abortion eliminates future revenue from customers who would otherwise need diapers, formula, medicine, clothing, and a myriad of extras for the rest of their lives.
Costco, for example, could make $200 now off of the death of an unborn child, or it could make $12,000 over 10 years, he poses.
"How in the world can it be for the benefit of the company to kill future customers?" Bowyer asks. "There's no way that it can be."
